Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2026 12:25 ET | Source: Hagens Berman Sobol Shapiro LLP

ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

Investors who lost money in ADMA after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 27, 2026 21:34 ET | Source: Hagens Berman Sobol Shapiro LLP

ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating

Investors who lost money in ADMA after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
March 04, 2025 13:50 ET | Source: Block & Leviton LLP

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Block & Leviton is investigating ADMA Biologics for potential securities fraud. Investors who lost money in ADMA should contact the firm to learn more.
October 17, 2024 11:00 ET | Source: Block & Leviton LLP

ADMA Biologics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Block & Leviton is investigating ADMA Biologics (Nasdaq: ADMA) for potential securities fraud. Investors who have lost money should contact the firm.
October 10, 2024 14:44 ET | Source: Block & Leviton LLP

ADMA Biologics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation

Block & Leviton is investigating ADMA Biologics for potential securities law violations. Investors who have lost money in ADMA should contact the firm.